Brian Sokutu
Senior Print Journalist
3 minute read
5 Jan 2021
5:43 pm

Covid-19 vaccines: These are SA’s top candidates

Brian Sokutu

South Africa may have to take a mix-and-match approach to its vaccinne rollout strategy, with three vaccines currently leading the race, each with its own benefits and drawbacks.

Picture for illustration. Picture: iStock

With over 240 Covid-19 vaccines in the development stages and over 42 clinical trials currently taking place worldwide, three candidate vaccines have emerged as frontrunners for use in South Africa. Government would most likely choose one of the AstraZeneca, Johnson & Johnson, or Pfizer/BioNTech jabs for rollout in the country in the second quarter of the year, with each of the three having its own benefits and drawbacks. While the Pfizer/BioNTech vaccine, with a 95% efficacy is the most effective, it is somewhat unsuitable for a mass inoculation drive locally, due to requiring storage at minus 70 degrees Celsius. This...